Advocacy intelligence hub — real-time data for patient organizations
Far East Bio-Tec Co., Ltd — PHASE2
Sanofi — PHASE3
The Affiliated Hospital of Qingdao University — NA
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — PHASE3
Sichuan Purity Pharmaceutical Technology Co., Ltd. — PHASE2
Longbio Pharma — PHASE2
Renmin Hospital of Wuhan University — NA
Desentum Oy — PHASE2
Guangdong Hengrui Pharmaceutical Co., Ltd — PHASE3
Genrix (Shanghai) Biopharmaceutical Co., Ltd. — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Dong-Xin Wang, MD, PhD
Peking University First Hospital, Beijing, CHINA
Johan Nilsson, MD, PhD
CTC Clinical Trial Consultants AB
Peter Couroux, MD
Inflamax Research Incorporated
Boehringer Ingelheim
The Institute for Liver Health II DBA Arizona Clinical Trials
📍 Peoria, Arizona
Alejandro Sanchez
Huntsman Cancer Institute/University of Utah
📍 Salt Lake City, Utah